Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Health

Corporate venturing continues to grow in February

Monthly analysis: February 2022


Mar 17, 2022

Seven essential tips for corporates venturing into the startup nation

Comment by Adam Salkin, a partner in one of Israel’s leading law firms, Herzog, Fox & Neeman

Mar 17, 2022

Israel ecosystem continues to scale up

Innovative region: Israel

Mar 17, 2022

Corporate venturing increases pace of innovation

Analysis by James Mawson, founder, Global Corporate Venturing and co-author of Transformative Innovation (with Christine Gulbranson)

Mar 17, 2022

Daily Deal Round Up: March 16, 2022

Bernstein Management and JBG Smith helped accommodation provider Placemakr raise $90m while crypto custodian Hex Trust netted $88m in a round co-led by Animoca Brands.

Mar 16, 2022

Deals: March 16, 2022

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Mar 16, 2022

MediLink meets Legend Capital to raise $70m

The immuno-oncology treatment developer secured series B funding from investors including Legend Capital, a year after its $50m series A round.

Mar 16, 2022

Daily Deal Round Up: March 15, 2022

MUFG Innovation Partners contributed to mobility financier Moove's $105m series A2 round while MS&AD and Nationwide helped insurance software developer Socotra raise $50m.

Mar 15, 2022

Texas Medical Center doubles fund to $50m

The healthcare provider has added $25m to its original commitment of $25m for TMC Venture Fund, to be deployed over the next decade.

Mar 15, 2022

Daily Deal Round Up: March 14, 2022

SAIC Motor’s Hengxu Capital helped allosteric drug developer Nutshell Therapeutics close a $40m round while cancer therapy developer Impact Therapeutics secured series D1 funding.

Mar 14, 2022

NGT nets T3 and Hadassit as partners

NGT HealthCare II Impact Fund has raised a $92m fund with T3 and Hadassit joining as strategic partners.

Mar 14, 2022

Analysis: DNAnexus obtains $200m

GV returned for a multimillion dollar round raised by the clinical data software provider, which is part of a space of much interest to corporate investors.

Mar 14, 2022
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here